[Guidelines of the Pharmaceutical Benefits Board for health economics evaluations. Cost-efficiency analysis from a national perspective].
Lundin
Douglas
D
Linköpings universitet.
Carlsson
Per
P
Levin
Lars-Ake
LA
Persson
Ulf
U
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004470:Economics, Medical; D017408:Guidelines as Topic; D007348:Insurance, Health / Q000191:economics; D019057:Quality-Adjusted Life Years; D013548:Sweden